Skip to main content
Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
71.78
-0.45 (-0.62%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Ionis Pharmaceuticals Revenue

In the year 2025, Ionis Pharmaceuticals had annual revenue of $943.71M with 33.83% growth. Ionis Pharmaceuticals had revenue of $203.33M in the quarter ending December 31, 2025, a decrease of -10.26%.

Revenue (ttm)
$943.71M
Revenue Growth
+33.83%
P/S Ratio
12.56
Revenue / Employee
$673,118
Employees
1,402
Market Cap
11.86B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025943.71M238.57M33.83%
Dec 31, 2024705.14M-82.51M-10.48%
Dec 31, 2023787.65M200.28M34.10%
Dec 31, 2022587.37M-223.09M-27.53%
Dec 31, 2021810.46M81.19M11.13%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Jazz Pharmaceuticals 4.27B
Genmab 3.72B
BioMarin Pharmaceutical 3.22B
Exelixis 2.32B
Arrowhead Pharmaceuticals 1.09B
Madrigal Pharmaceuticals 958.40M
Ascendis Pharma 845.52M
Axsome Therapeutics 638.50M
Revenue Rankings

IONS News

More News